Reducing the Incidence of Non-A,Non-B Post-Transfusion Hepatitis by Testing Donor Blood for Alanine Aminotransferase
Authors:
- Mark C. HornbrookMHMark C. Hornbrook
- Roger Y. DoddRDRoger Y. Dodd
- Philip JacobsPJPhilip Jacobs
- Leonard I. FriedmanLFLeonard I. Friedman
- Kenneth E. ShermanKSKenneth E. Sherman
- 18 November 1982
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 307 (21) , 1315-1321
Abstract
Recent studies have established a relation between elevated alanine aminotransferase levels in donor blood and the incidence of non-A,non-B hepatitis in recipients of such blood. Routine testing of donor blood for alanine aminotransferase activity in order to reduce hepatitis is not currently supported, largely because the results of such testing are unknown.Keywords
This publication has 12 references indexed in Scilit:
- Alanine Aminotransferase Levels among Volunteer Blood Donors: Geographic Variation and Risk FactorsThe Journal of Infectious Diseases, 1982
- Report of the ad hoc committee on ALT testing*Transfusion, 1982
- Prevention of Posttransfusion Hepatitis: Cost-effective or Not?1981
- Donor transaminase and recipient hepatitis. Impact on blood transfusion servicesJAMA, 1981
- Serum Alanine Aminotransferase of Donors in Relation to the Risk of Non-A,Non-B Hepatitis in RecipientsNew England Journal of Medicine, 1981
- Post-Transfusion Viral Hepatitis and the TTVSNew England Journal of Medicine, 1981
- Chronic Non-A, Non-B Hepatitis Carrier StateNew England Journal of Medicine, 1980
- The Dominant Role of Non-A, Non-B in the Pathogenesis of Post-transfusion Hepatitis: A Clinical AssessmentClinics in Gastroenterology, 1980
- On the Use of Distributional Weights in Social Cost-Benefit AnalysisJournal of Political Economy, 1978
- Development of Chronic Liver Disease after Acute Non-A, Non-B Post-Transfusion HepatitisGastroenterology, 1977